L'ENTREPRISE FONDÉE PAR DR RATH DANS LE DOMAINE DE LA SANTÉ EST UNIQUE AU MONDE:
LA TOTALITÉ DE SES BÉNÉFICES EST REVERSÉE À UNE FONDATION D'UTILITÉ PUBLIQUE. Lisez plus loin…

Dr. Rath Health Foundation

Dr. Rath Health Foundation

 

Inhibitory effects of ascorbic acid, proline and lysine supplementation on Matrigel invasion by human breast cancer cells, MDA-MB231.

S Netke, Ph.D., V Ivanov , MD. Ph.D., W. Roomi, Ph. D., A Niedzwiecki, Ph. D., Matthias Rath, M.D.

Presented at: 19th Annual Miami Breast Cancer Conference, Miami Beach, Florida, February 27 – March 3, 2002.
Published in: Conference Proceedings

19th Annual Miami Breast Cancer Conference

Worldwide, breast cancer is the most prevalent cancer in women. Metastasis potential and invasiveness of breast cancer are attributed to up-regulation of matrix metalloproteinases (MMPs).

In the current study, we studied the effect of a natural anti-cancer formula on invasive potential of human breast cancer cell lines. EF is a specific mixture of lysine, proline, ascorbic acid and epigallocatechin, which we have shown previously that have a very potent synergistic antitumor activity through inhibiting extracellular matix invasion by cancer cells.

In this study we tested effect of a natural anti-cancer formula on estrogen-receptor positive (ER+) MCF-7 and estrogen-receptor negative (ER-) MDA-MB-231 breast cancer cell lines. Metastatic parameters: expression of MMPs by zymography, cellular invasion through Matrigel and proliferation/cytotoxicity by MTT assay were studied. Invasion of MBA-MD-231 through matrigel was inhibited by 50%, 60% and 95% by 10, 50 and 100 ug/ml of EF respectively. EF was not toxic to MDA-MB-231 at 10ug/ml, showed slight toxicity at 100ug/ml.

However, it exhibited significant toxicity at 1000 ug/ml. Neither MMP-2 nor MMP-9 were detected by gelatinase zymography. In contrast, the natural anti-cancer formula was not toxic to MCF-7 at 10, 50, 100 and 500 ug/ml, and exhibited slight toxicity at 1000 ug/ml. Interestingly, MCF-7 was not invasive through Matrigel and did not express any MMP activity. These results suggest that the natural anti-cancer formula is valuable and promising candidate for ER- , MDA-MB-231 breast cancer cells. Further studies will be required for ER+ , MCF-7 breast cancer cells to determine the efficacy of a natural anti-cancer formula.